Literature DB >> 26934510

Loss of inhibitory tone on spinal cord dorsal horn spontaneously and nonspontaneously active neurons in a mouse model of neuropathic pain.

Maria Carmen Medrano1, Dhanasak Dhanasobhon1,2, Ipek Yalcin1, Rémy Schlichter1,2, Matilde Cordero-Erausquin1,3.   

Abstract

Plasticity of inhibitory transmission in the spinal dorsal horn (SDH) is believed to be a key mechanism responsible for pain hypersensitivity in neuropathic pain syndromes. We evaluated this plasticity by recording responses to mechanical stimuli in silent neurons (nonspontaneously active [NSA]) and neurons showing ongoing activity (spontaneously active [SA]) in the SDH of control and nerve-injured mice (cuff model). The SA and NSA neurons represented 59% and 41% of recorded neurons, respectively, and were predominantly wide dynamic range (WDR) in naive mice. Nerve-injured mice displayed a marked decrease in the mechanical threshold of the injured paw. After nerve injury, the proportion of SA neurons was increased to 78%, which suggests that some NSA neurons became SA. In addition, the response to touch (but not pinch) was dramatically increased in SA neurons, and high-threshold (nociceptive specific) neurons were no longer observed. Pharmacological blockade of spinal inhibition with a mixture of GABAA and glycine receptor antagonists significantly increased responses to innocuous mechanical stimuli in SA and NSA neurons from sham animals, but had no effect in sciatic nerve-injured animals, revealing a dramatic loss of spinal inhibitory tone in this situation. Moreover, in nerve-injured mice, local spinal administration of acetazolamide, a carbonic anhydrase inhibitor, restored responses to touch similar to those observed in naive or sham mice. These results suggest that a shift in the reversal potential for anions is an important component of the abnormal mechanical responses and of the loss of inhibitory tone recorded in a model of nerve injury-induced neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26934510     DOI: 10.1097/j.pain.0000000000000538

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  Hypoxia-induced carbonic anhydrase mediated dorsal horn neuron activation and induction of neuropathic pain.

Authors:  Marlene E Da Vitoria Lobo; Nick Weir; Lydia Hardowar; Yara Al Ojaimi; Ryan Madden; Alex Gibson; Samuel M Bestall; Masanori Hirashima; Chris B Schaffer; Lucy F Donaldson; David O Bates; Richard Philip Hulse
Journal:  Pain       Date:  2022-03-29       Impact factor: 7.926

2.  Spontaneous Multimodal Neural Transmission Suggests That Adult Spinal Networks Maintain an Intrinsic State of Readiness to Execute Sensorimotor Behaviors.

Authors:  Maria F Bandres; Jefferson Gomes; Jacob G McPherson
Journal:  J Neurosci       Date:  2021-08-11       Impact factor: 6.167

3.  Small-Conductance Ca2+-Activated K+ Channel 2 in the Dorsal Horn of Spinal Cord Participates in Visceral Hypersensitivity in Rats.

Authors:  Yu Song; Jun-Sheng Zhu; Rong Hua; Lei Du; Si-Ting Huang; Robert W Stackman; Gongliang Zhang; Yong-Mei Zhang
Journal:  Front Pharmacol       Date:  2018-08-03       Impact factor: 5.810

4.  Cell type-specific calcium imaging of central sensitization in mouse dorsal horn.

Authors:  Charles Warwick; Joseph Salsovic; Junichi Hachisuka; Kelly M Smith; Tayler D Sheahan; Haichao Chen; James Ibinson; H Richard Koerber; Sarah E Ross
Journal:  Nat Commun       Date:  2022-09-03       Impact factor: 17.694

5.  Ethanol-induced enhancement of inhibitory synaptic transmission in the rat spinal substantia gelatinosa.

Authors:  Akihiro Yamada; Kohei Koga; Kazuhiko Kume; Masahiro Ohsawa; Hidemasa Furue
Journal:  Mol Pain       Date:  2018-11-19       Impact factor: 3.395

Review 6.  Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators.

Authors:  Eiichi Kumamoto
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.